Testing effectiveness (Phase 2)Looking for participantsNCT06890923
What this trial is testing
Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis
Who this might be right for
Non-Active Secondary Progressive Multiple Sclerosis
Tiziana Life Sciences LTD 55